These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20229604)

  • 41. Glucuronidation of 3'-azido-3'-deoxythymidine by rat and human liver microsomes.
    Cretton EM; Waterhous DV; Bevan R; Sommadossi JP
    Drug Metab Dispos; 1990; 18(3):369-72. PubMed ID: 1974201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Species differences in distribution and prediction of human V(ss) from preclinical data.
    Berry LM; Li C; Zhao Z
    Drug Metab Dispos; 2011 Nov; 39(11):2103-16. PubMed ID: 21852367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey.
    Sharer JE; Shipley LA; Vandenbranden MR; Binkley SN; Wrighton SA
    Drug Metab Dispos; 1995 Nov; 23(11):1231-41. PubMed ID: 8591724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biotransformation of letrozole in rat liver microsomes: effects of gender and tamoxifen.
    Tao X; Piao H; Canney DJ; Borenstein MR; Nnane IP
    J Pharm Biomed Anal; 2007 Feb; 43(3):1078-85. PubMed ID: 17045772
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Species differences in the metabolism of ritobegron in vitro and assessment of potential interactions with transporters and cytochrome P450 enzymes.
    Abe Y; Ota E; Harada H; Kanbe H; Kojima Y; Kanazawa T; Endo T; Murakami M; Kobayashi M
    Pharmazie; 2015 Jan; 70(1):38-46. PubMed ID: 25975097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hydroxylation of 4,4'-methylenebis(2-chloroaniline) by canine, guinea pig, and rat liver microsomes.
    Chen TH; Kuslikis BI; Braselton WE
    Drug Metab Dispos; 1989; 17(4):406-13. PubMed ID: 2571481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of in vivo enantiomeric compositions by modeling in vitro metabolic profiles.
    Wang M; Wang Q; Cai H; Sleczka B; D'Arienzo C; Josephs J; Ye XY; Robl J; Gordon D; Rodrigues D; Harper T
    J Pharm Sci; 2010 Jul; 99(7):3234-45. PubMed ID: 20112434
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigation of the utility of published in vitro intrinsic clearance data for prediction of in vivo clearance.
    Nagilla R; Frank KA; Jolivette LJ; Ward KW
    J Pharmacol Toxicol Methods; 2006; 53(2):106-16. PubMed ID: 16188462
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Organ and species differences in microsomal activation of methyldopa.
    Dybing E
    Drug Metab Dispos; 1976; 4(6):513-6. PubMed ID: 11971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of Commonly Used and New Methods to Determine Small Molecule Non-Specific Binding to Human Liver Microsomes.
    Wang T; Whitcher-Johnstone A; Scaringella YS; Keith-Luzzi M; Shao J; Taub ME; Chan TS
    J Pharm Sci; 2024 Jul; 113(7):1987-1995. PubMed ID: 38615815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of Tissue Binding in Three Tissues across Five Species and Prediction of Volume of Distribution from Plasma Protein and Tissue Binding with an Existing Model.
    Hsu F; Chen YC; Broccatelli F
    Drug Metab Dispos; 2021 Apr; 49(4):330-336. PubMed ID: 33531412
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systematic Evaluation of Wajima Superposition (Steady-State Concentration to Mean Residence Time) in the Estimation of Human Intravenous Pharmacokinetic Profile.
    Lombardo F; Berellini G; Labonte LR; Liang G; Kim S
    J Pharm Sci; 2016 Mar; 105(3):1277-87. PubMed ID: 26886320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Fragment-Based Approach for the Computational Prediction of the Nonspecific Binding of Drugs to Hepatic Microsomes.
    Nair PC; McKinnon RA; Miners JO
    Drug Metab Dispos; 2016 Nov; 44(11):1794-1798. PubMed ID: 27543205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhancing Multi-species Liver Microsomal Stability Prediction through Artificial Intelligence.
    Long TZ; Jiang DJ; Shi SH; Deng YC; Wang WX; Cao DS
    J Chem Inf Model; 2024 Apr; 64(8):3222-3236. PubMed ID: 38498003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HLM-beads: Rapid Assessment of Nonspecific Binding to Human Liver Microsomes Using Magnetizable Beads.
    Wang T; Whitcher-Johnstone A; Keith-Luzzi M; Chan TS
    Drug Metab Dispos; 2021 Dec; 49(12):1056-1062. PubMed ID: 34561223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of structural modifications on drug-hepatic microsomal interactions [proceedings].
    Houston JB; Al-Gailany KA; Bridges JW
    J Pharm Pharmacol; 1977 Dec; 29 Suppl():76P. PubMed ID: 22710
    [No Abstract]   [Full Text] [Related]  

  • 57. Development of QSAR models for microsomal stability: identification of good and bad structural features for rat, human and mouse microsomal stability.
    Hu Y; Unwalla R; Denny RA; Bikker J; Di L; Humblet C
    J Comput Aided Mol Des; 2010 Jan; 24(1):23-35. PubMed ID: 19937264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Colorimetric determination of N-hydroxylated metabolites in microsomal studies.
    Bélanger PM; Grech-Bélanger O; Blouin M
    Anal Biochem; 1981 Nov; 118(1):47-52. PubMed ID: 7337215
    [No Abstract]   [Full Text] [Related]  

  • 59. Consideration of the Unbound Drug Concentration in Enzyme Kinetics.
    Waters NJ; Obach RS; Di L
    Methods Mol Biol; 2021; 2342():113-145. PubMed ID: 34272693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from In Vivo Monkey Pharmacokinetics Study and In Vitro Metabolic Stability Tests Using Hepatocytes.
    Nishimuta H; Watanabe T; Bando K
    AAPS J; 2019 Jan; 21(2):20. PubMed ID: 30673906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.